1.The Effects of Paracetamol, Ketorolac, and Paracetamol Plus Morphine on Pain Control after Thyroidectomy.
Sun Yeul LEE ; Won Hyung LEE ; Eun Ha LEE ; Kyu Cheol HAN ; Young Kwon KO
The Korean Journal of Pain 2010;23(2):124-130
BACKGROUND: The aim of this study was to compare the efficacy of ketorolac, paracetamol, and paracetamol plus morphine on pain relief after thyroidectomy. METHODS: Eighty patients were randomly allocated to one of the 4 groups: normal saline (group C), ketorolac 30 mg (group K), paracetamol 1 g (group P), and paracetamol 700 mg plus morphine 3 mg (group PM). Each regimen was administered intravenously (IV) 30 min. before the end of surgery. If pain was not relieved, patients received an IV bolus of pethidine hydrochloride 25 mg. Pain intensity using a visual analogue scale (VAS) was recorded at 0.5, 1, 2, 4, and 6 hr after the end of surgery. RESULTS: VAS at 0.5 and 1 hr after the end of surgery were significantly lower in group K, group P, and group PM than in group C (P < 0.05). The number of patients receiving pethidine hydrochloride at 0.5 and 1 hr after the end of surgery was significantly lower in group K, group P, and group PM than in group C (P < 0.05). There was no significant difference among the groups in the incidences of adverse events associated with study medications and patient satisfaction (P > 0.05). CONCLUSIONS: Paracetamol 1 g IV possesses a similar analgesic efficacy to ketorolac 30 mg IV after thyroidectomy. Paracetamol may represent an alternative to ketorolac for pain prevention after mildly to moderately painful surgery in situations where the use of NSAIDs is unsuitable.
Acetaminophen
;
Analgesics
;
Anti-Inflammatory Agents, Non-Steroidal
;
Humans
;
Incidence
;
Ketorolac
;
Meperidine
;
Morphine
;
Patient Satisfaction
;
Thyroidectomy
2.A clinical review of the patients with upper gastrointestinal bleed- ing entered to emergency room and factors influencing the outcome.
Sun Jin KIM ; Pyeong Rang CHOO ; Won Sook GYE ; Ho Cheol SHIN ; Eun Sook PARK
Journal of the Korean Academy of Family Medicine 1991;12(2):20-27
No abstract available.
Emergencies*
;
Emergency Service, Hospital*
;
Humans
3.Effects of octreotide on the contractility of isolated rat vas deferens.
Sun Ae JANG ; Oh Cheol KWON ; Jeoung Hee HA ; Kwang Youn LEE ; Won Joon KIM
Yeungnam University Journal of Medicine 1993;10(1):144-156
This study was performed to investigate the effect of octreotide on the contractility of rat vas deferens. The -smooth muscle strips isolated from the prostatic portion were myographied in isolated organ bath. Electric -field stimulation (monophasic square wave, duration : 1. mSec, voltage : 50 V, frequency : 5 Hz or 30 Hz, train : 10 Sec) produced reproducible contraction. The contraction was composed of two component, first phasic component (FPC) and second tonicc component (STC).. These contractions were abolished by -tetrodotoxin (1 microM). Octreotide inhibited the field stimulation induced contractions both FPC and STC concentration- dependently. The FPC was decreased by a desentization of purinergic receptor by pretreatment of mATP, and the STC was decreased by pr,,creatment of reserpine (3 mg/kg, EP) 24 hours before experiments. Octreotide reduced the field stimulation induced contraction in the presence of mATP and of reserpinized muscle strips. The inhibitory effect of octreotide was more potent at 5 Hz than at 30 Hz. Octreotide did not affect basal ton and exogenous norepinephrine- or ATP-induced contraction. These results suggest that octreotide inhibit the contractility of the isolated rat vas deferens by inhibition of the release of neurotransmitters, both ATP and norepinephrine from adrenergic nerve terminal.
Adenosine Triphosphate
;
Animals
;
Baths
;
Neurotransmitter Agents
;
Norepinephrine
;
Octreotide*
;
Rats*
;
Reserpine
;
Vas Deferens*
4.A Case of Hypogonadotrophic Hypogonadism due to Intrasellar Arachnoid Cyst.
Hyun Hee JO ; Kyeong A YEO ; Jin Hong KIM ; Ki Cheol KIL ; Hyoung Ju CHOI ; Sun Won YOO
Korean Journal of Obstetrics and Gynecology 2000;43(7):1290-1293
Primary amenorrhea due to intrasella arachnoid cyst is a very rare disease and require careful and frequent evaluation because may produce intracranial hemorrhage, elevated intracranial pressure and rapid expansion. Surgical intervention is needed only when visual disturbance, hypopituitarism or enlarging lesion is shown. Thus, we present a case of primary amenorrhea due to intrasella arachnoid cyst which was resected through the transsphenoidal approach.
Amenorrhea
;
Arachnoid*
;
Female
;
Hypogonadism*
;
Hypopituitarism
;
Intracranial Hemorrhages
;
Intracranial Hypertension
;
Rare Diseases
5.A Case for Treatment of Precocious Pseudopuberty Associated with Follicular cyst.
Hyoung Ju CHOI ; Ki Cheol KIL ; Sun Won YOO ; Jang Heub KIM ; Jin Hong KIM ; Soo Pyoung KIM
Korean Journal of Obstetrics and Gynecology 2000;43(4):742-746
Small follicular cysts are common findings in the ovaries of prepubertal girls, and in most cases, they are of no clinical importance. Ocassionally these cysts may enlarge and continue to produce estrogen, resulting in signs of precocious sexual development and vaginal bleeding. We have experienced a case of a precocious pseudopuberty causing ovarian follicular cyst which was treated by exploratory laparotomy. we present this case with a brief review of literatures
Estrogens
;
Female
;
Follicular Cyst*
;
Humans
;
Laparotomy
;
Ovary
;
Sexual Development
;
Uterine Hemorrhage
6.A study on the domestice accidents in Seoul.
Won Sook KYE ; Sun Jin KIM ; Pheung Rang CHOO ; Hyun Ju BOO ; Ho Cheol SHIN ; Eun Sook PARK
Journal of the Korean Academy of Family Medicine 1991;12(10):40-50
No abstract available.
Seoul*
7.Full mouth rehabilitation of severely worn dentition using posterior implants: a clinical report.
Hyun Sun KANG ; Cheol Won LEE ; Won Sup LEE ; Su Young LEE
Journal of Dental Rehabilitation and Applied Science 2016;32(3):255-262
This clinical report focuses on the treatment of a patient with esthetic and functional impairments due to severe worn dentition. Absence of posterior support for a prolonged period require comprehensive prosthetic restoration. Accurate clinical and radiographic examinations, diagnostic wax-up, and occlusal vertical dimension evaluation were performed and the degree of patient adaptability was evaluated using an interim restoration. After 8 weeks of stabilization with interim restoration and confirmation of absence of any abnormal findings, definitive prostheses were fabricated. Satisfactory functional and esthetic outcomes were observed after 6 months of follow-up.
Dentition*
;
Follow-Up Studies
;
Humans
;
Mouth Rehabilitation*
;
Mouth*
;
Prostheses and Implants
;
Tooth Wear
;
Vertical Dimension
8.Effects of Verapamil Cardioplegia on the Hypertrophied Left Ventricle Undergoing Cardiopulmonary Bypass.
Won Sun PARK ; Young Lan KWAK ; Chun Soo LEE ; Jin Ho KIM ; Won Cheol KANG ; Yong Woo HONG
Korean Journal of Anesthesiology 2000;39(6):804-810
BACKGROUND: Verapamil, a calcium channel blocker, is known to protect the myocardium against ischemia and reperfusion injury. The hypertrophied myocardium is at greater risk for ischemic damage compared to the normal heart during cardiopulmonary bypass (CPB). We evaluated the myocardial protective effect of verapamil cardioplegia on the hypertrophied left ventricle during CPB. METHODS: Seventeen patients with end-diastolic anterior wall thickness (DAWT) greater than 11 mm in an M-mode echocardiogram were consented to participate in this study. Patients were randomized to receive either standard hyperkalemic blood cardioplegic solution (n = 8) or the same solution with verapamil (n = 9). End systolic anterior wall thickeness (SAWT) and DAWT were measured by an M-mode echocardiogram and the left ventricular ejection fraction (LVEF) was calculated with a 2-dimension echocardiogram before and after CPB. Simultaneously, hemodynamic variables were measured. RESULTS: There was no significant difference of DAWT and LVEF between both groups before and after CPB. DAWT was increased after CPB but this increase was attenuated by verapamil in patients with LVH. LVEF was decreased in both groups after CPB and the decrease in the verapamil group was not statistically significant but in the control group. Cardiac index and stroke volume index didn't show any significant differences between the two groups after CPB, either. CONCLUSIONS: DAWT increased which means myocardial edema was significant in patients with LVH; however, a verapamil cardioplegic solution decreased the amount of increase in DAWT. However, theverapamil cardioplegic solution didn't improve the hypertophied ventricular systolic function after CPB.
Calcium Channels
;
Cardioplegic Solutions
;
Cardiopulmonary Bypass*
;
Edema
;
Heart
;
Heart Arrest, Induced*
;
Heart Ventricles*
;
Hemodynamics
;
Humans
;
Ischemia
;
Myocardium
;
Reperfusion Injury
;
Stroke Volume
;
Verapamil*
9.Successful desensitization for treatment of an exfoliative dermatitis to allopurinol.
Jung Won PARK ; Chein Soo HONG ; Yeong Yeon YUN ; Cheol Woo KIM ; Jung Sun KIM ; Won Chung JUNG ; Jung Yeop PARK ; Young Jun CHO ; Ae Jung HUH
Journal of Asthma, Allergy and Clinical Immunology 1999;19(6):980-984
Allopurinol is widely used for chronic tophaceous gout as a uric acid lowering agent. Hypersensitivity to allopurinol occurrs in about 10% of patients, which limits the usage of allopurinol. The successful oral and intravenous desensitization of allopurinol has been reported worldwide since 1976. We recently experienced a 51-year-old male patient with gouty arthritis and hyperuricemia, who had previously experienced skin rash after allopurinol treatment. When allopurinol was retried, erythematous and foliative skin rash developed on entire body. Because allopurinol was essential in controlling hyperuricemia, the oral desensitization of allopurinol was tried. We report successful rapid oral allopurinol desensitization in the patient with chronic tophaceous gout, who exhibited exfoliative dermatitis as allopurinol hypersensitivity.
Allopurinol*
;
Arthritis, Gouty
;
Dermatitis, Exfoliative*
;
Exanthema
;
Gout
;
Humans
;
Hypersensitivity
;
Hyperuricemia
;
Male
;
Middle Aged
;
Uric Acid
10.Development of External Quality Controls for Human Immunodeficiency Virus Antigen/Antibody Tests in Korea.
Dong Hee SEO ; Yeo Rin CHOI ; Won Woong CHOI ; Cheol Hee YOON ; Byeong Sun CHOI ; Yoon Seok CHUNG ; Chun KANG
Journal of Laboratory Medicine and Quality Assurance 2018;40(2):92-100
BACKGROUND: Quality control is important for accurate diagnosis of human immunodeficiency virus (HIV) infection, and proficiency testing with external quality controls is an important part of quality control. This study intended to develop and supply customized external quality controls for HIV antigen/antibody testing fitted with currently used reagents for standardization of HIV infection diagnosis and evaluation of HIV testing competency of laboratories in Korea. METHODS: Serological tests and inactivation were performed on the obtained HIV antibody positive plasma. To manufacture quality controls having the required antibody titers, dilution ratio was searched using VIDAS (bioMérieux, France), Architect (Abbott Laboratories, USA), and Cobas 8000 (Roche Diagnostics, Germany) analyzers. Diluted source plasma was divided into aliquots after filtering. Homogeneity and stability of the produced external quality controls were evaluated. RESULTS: The collected HIV antibody positive plasma was confirmed by Western blot. Dilution ratios for source plasma were produced for each analyzer showing signal-to-cut-off 2–3, 5–7, and 15–16 reactivity. Diluted plasma was made to 1 mL aliquots and total set of 1,500 external quality controls for HIV antigen/antibody were manufactured. Produced controls satisfied the required criteria of homogeneity and showed less than 10% coefficient of variation for stability except negative controls. CONCLUSIONS: Customized external quality controls were developed and qualified for HIV testing reagents used in Korea. Continuous external quality control assessment for HIV tests with controls would be required.
Blotting, Western
;
Diagnosis
;
HIV Infections
;
HIV*
;
Humans*
;
Indicators and Reagents
;
Korea*
;
Plasma
;
Quality Control*
;
Serologic Tests